Guide for patients & caregivers
Prothrombin Gene Mutation (G20210A): What Does a Positive Result Mean?
Prothrombin gene mutation (G20210A) explained: what one or two copies mean, how it differs from a PT/INR test, family testing questions and clot warning signs.
Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles
What does a prothrombin gene mutation result mean?
A positive prothrombin gene mutation (G20210A) result means you carry an inherited change in the F2 gene that leads the body to make more prothrombin, a clotting protein. This raises the chance of clots in the veins, such as deep vein thrombosis and pulmonary embolism. Cleveland Clinic notes that most people born with the mutation will not develop an abnormal clot in their lifetime.
This guide is for adults reading a genetic result that says prothrombin G20210A, factor II mutation or F2 variant detected. It explains the wording, what affects risk and what to ask. It cannot estimate your personal risk or decide on treatment.
When should you get urgent care?
The mutation itself causes no symptoms. Healthdirect advises seeing a doctor straight away for signs of a DVT, such as a red, swollen, painful leg. Pain and swelling can also affect an arm.
Call emergency services if you have:
- Sudden shortness of breath or trouble breathing.
- Chest pain.
- A racing heartbeat, dizziness or fainting.
- Coughing up blood, especially with leg pain or swelling.
- Any of these signs while pregnant or soon after giving birth.
One copy or two: heterozygous vs homozygous
Prothrombin thrombophilia is the second most common inherited clotting tendency after factor V Leiden. MedlinePlus Genetics states that 2 to 5 percent of Americans of European ancestry carry the variant, and that it is much less common in African, Asian and Native American populations. Many people learn they carry it after a clot, because a relative had a clot or a positive test, or as part of a wider panel of clotting tests.
Most people with this result are heterozygous, meaning one changed copy of the F2 gene and one usual copy. MedlinePlus Genetics states that one copy makes the risk of harmful clots two to five times greater than average. That sounds large, but it starts from a low baseline.
Homozygous means two changed copies, one from each parent. MedlinePlus explains that this carries a higher risk than one copy and that clots may happen more often and at a younger age. It also notes that many people with two copies never develop a harmful clot.
Cleveland Clinic describes the prothrombin mutation as the weakest of the inherited clotting disorders in terms of clot risk. Risk rises when it is combined with another clotting disorder, such as factor V Leiden, so check whether your report lists more than one result.
Is this the same as a prothrombin time (PT/INR) test?
No. The names are similar, which causes confusion. A prothrombin gene test looks at your DNA for the G20210A change. The result does not change over time.
A prothrombin time (PT/INR) test is a different blood test. MedlinePlus explains that it measures how many seconds a blood sample takes to clot, and it is often used to check how well warfarin is working. A PT/INR result does not show whether you carry the gene mutation, and the gene result is not a measure of clotting time. If your report is unclear, ask which test was done.
What else raises clot risk with this mutation?
MedlinePlus Genetics lists factors that add to risk in people with prothrombin thrombophilia: surgery, injury, air travel, obesity, a family history of clots, pregnancy, and oestrogen used for contraception or menopause symptoms. NHLBI adds that risk rises with age and that most clots involve more than one risk factor.
Pregnancy: Cleveland Clinic explains that people who have never had a DVT or pulmonary embolism usually do not need a blood thinner in pregnancy because of this mutation alone. Those with a past clot may be offered preventive injections, depending on the details. Your maternity team or haematologist will decide based on your full history.
Contraception, HRT and travel: ask whether oestrogen-containing options suit you. On long trips, Healthdirect suggests walking every 1 to 2 hours, calf stretches, drinking water and avoiding alcohol. Ask whether anything more is advised for you.
Should family members be tested?
The mutation is inherited in an autosomal dominant pattern, so one copy is enough to raise risk. Cleveland Clinic notes that a heterozygous parent has a 50 percent chance of passing the change to each child, and a homozygous parent will pass it on to every child.
That does not mean every relative needs a test. A result could matter to a relative who is planning pregnancy, considering oestrogen, or facing major surgery, but it may not change care for others. A clinician or genetic counsellor can explain the benefits and limits. Testing a relative is their own choice, so share the information and let them decide.
If relatives have had clots, write down who, at what age and what the circumstances were. This history often matters as much as the gene result.
Does the mutation need treatment, and what about blood thinners?
Cleveland Clinic states that there is no specific treatment for the mutation itself. Care focuses on treating clots and lowering risk at higher-risk times, such as after surgery or around pregnancy.
If you have had a clot, NHLBI explains that blood thinners may be needed for several months or for life, depending on the cause of the clot and other factors. Never stop or change a blood thinner because of a gene result. Talk to the prescriber first. The NHS medicine page for rivaroxaban, one blood thinner, warns that stopping suddenly can be dangerous.
Questions to ask your clinician
Bring the full report and any past clot records.
- Is my result heterozygous or homozygous, and was factor V Leiden or anything else tested?
- Was a D-dimer or PT/INR test also done, and how is it different from this result?
- Does this result change my care now, or only at certain times such as surgery or pregnancy?
- Which contraception or menopause treatments are suitable for me?
- If I take a blood thinner, how long is it planned for and who reviews it?
- Should my children, siblings or parents be offered testing, and how would they arrange it?
How can similar cases help you prepare?
On SameCase, patients and verified doctors share de-identified cases. Seeing how others with a prothrombin gene mutation talked through family testing, pregnancy plans or travel can help you prepare clearer questions. Similar cases cannot predict your own risk or replace your clinician's advice. We suggest noting the questions they raise and taking them to your next appointment.
Sources and further reading
- MedlinePlus Genetics: Prothrombin thrombophilia
- Cleveland Clinic: Prothrombin gene mutation (factor II)
- MedlinePlus Lab Tests: Prothrombin time test and INR (PT/INR)
- Healthdirect Australia: Deep vein thrombosis
- NHLBI: Venous thromboembolism causes and risk factors
- NHLBI: Venous thromboembolism treatment
- NHS: Rivaroxaban, a blood-thinning medicine
For patients & caregivers
Share your case and learn from others
Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.